Abstract
There are two major clinical presentations of the metabolic myopathies: one is fixed, usually slowly progressive weakness; the other corresponds exactly to the main theme of this symposium, exercise intolerance, muscle contracture and pain. We will confine our review to recent developments in this second group of disorders. Although acute muscle breakdown (rhabdomyolysis) with myoglobinuria is not explicitly mentioned in the title of the book, in fact most, if not all, of the metabolic myopathies under consideration can cause myoglobinuria and are listed in Table 1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tein I, DiMauro S, Rowland LP (1992) Myoglobinuria. In: Rowland LP, Di Mauro S (eds) Handbook of Clinical Neurology. Elsevier, Amsterdam, Vol 62, pp 553–593
Holt IJ, Harding AE, Morgan Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717–719
Wallace DC, Singh G, Lott MT et al (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242:1427–1430
Haller RG, Lewis SF (1984) Pathophysiology of exercise performance in muscle disease. Med Sci Sports Exerc 16:456–459
Kreuder J, Borkhardt A, Repp R et al (1996) Inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. New Engl J Med 334:1100–1104
Tsujino S, Shanske S, Sakoda S, Fenichel G, Di Mauro S (1993) The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency. Am J Hum Genet 52:472–477
DiMauro S, Servidei S, Tsujino S (1997) Disorders of carbohydrate metabolism: Glycogen storage diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The Molecular and Genetic Basis of Neurological Disease. Boston, Butterworth-Heinemann, pp 1067–1097
Bartram C, Edwards R, Clague J, Beynon RJ (1993) McArdle’s disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases. Hum Mol Genet 2:1291–1293
El-Schahawi M, Tsujino S, Shanske S, DiMauro S (1996) Diagnosis of McArdle’s disease by molecular genetic analysis of blood. Neurology 47:579–580
Vorgerd M, Kubisch C, Burwinkel B et al (1998) Mutation analysis in myophosphorylase deficiency (McArdle’s disease). Ann Neurol 43:326–331
Martinuzzi A, Tsujino S, Vergani L et al (1996) Molecular characterization of myophosphorylase deficiency in a group of patients from Northern Italy. J Neurol Sci 137:14–19
Andreu AL, Bruno C, Gamez J et al (1998) Molecular genetic analysis of McArdle’s disease in Spanish patients. Ann Neurol 45:127–130
a. Andreu AL, Bruno C, Dunne TC, et al. A nonsense mutation (G 15059 A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol 1999; 45:127–130
Tonin P, Lewis P, Servidei S, DiMauro S (1990) Metabolic causes of myoglobinuria. Ann Neurol 27:181–185
Angelos S, Valberg SJ, Smith BP et al (1995) Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in six related Charolais cattle. Muscle and Nerve 18:736–740
Tsujino S, Shanske S, Valberg SJ, Cardinet GH, Smith BS, Di Mauro S (1995) Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle’s disease. Neuromusc Disord 6:19–26
Tan P, Allen JG, Wilton SD, Akkari PA, Huxtable CR, Laing NG (1997) A splice-site mutation causing ovine McArdle’s disease. Neuromusc Disord 7:336–342
Morisaki T, Gross M, Morisaki H, Pongratz D, Zollner N, Holmes EW (1992) Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Nat Acad Sci USA 89:6457–6461
Sabina RL, Holmes EW (1995) Myoadenylate deaminase deficiency. In: Engel AG, Franzini-Armstrong c (eds) myology. New York: McGraw-Hill, New York, vol II, pp 1769–1780
Tsujino S, Servidei S, Tonin P, Azan G, DiMauro S (1994) Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am J Hum Genet 54:812–819
Tsujino S, Shanske S, Carroll JE, Sabina RL, DiMauro S (1995) Double trouble: Combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci. Neuromusc Disord 5:263–266
Bruno C, Minetti C, Shanske S et al (1998) Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria. Neurology 50:296298
Rubio JC, Martin MA, Bautista J, Campos Y, Segura D, Arenas J (1997) Association of genetically proven deficiencies of myophosphorylase and AMP deaminase: a second case of “double trouble”. Neuromusc Disord 7:387–389
Gellera C, Verderio E, Floridia G et al (1994) Assignment of the human carnitine palmitoyltransferase II gene (CPPT II) to chromosome Ip32. Genomics 24:195–197
Finocchiaro G, Taroni F, Rocchi M et al (1991) cDNA cloning. sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase. Proc Nat Acad Sci USA 88:661–665
Taroni F, Verderio E, Dworzak F, Willems PJ, Cavadini P, DiDonato S (1993) Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nature Genet 4:314–320
Kaufmann P, El-Schahawi M, DiMauro S (1997) Carnitine palmitoyltransferase II deficiency: Diagnosis by molecular analysis of blood. Mol Cell Biochem 174:237–239
Di Donato S (1997) Diseases associated with defects of beta-oxidation. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The Molecular and Genetic Basis of Neurological Disease. Boston, Butterworth-Heinemann, pp 939–956
Kamijo T, Indo Y, Souri M et al (1997) Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: A new disorder of mitochondria] fatty acid beta-oxidation. Pediatr Res 42:569–576
Schaefer J, Jackson S, Dick DJ, Turnbull DM (1996) Trifunctional enzyme deficiency: Adult presentation of a usually fatal beta-oxidation defect. Ann Neurol 40:597–602
Smelt AH, Poorthuis BJ, Onkenhout W et al (1998) Very long chain acyl-coenzyme A dehydrogenase deficiency with adult onset. Ann Neurol 43:540–544
Minetti C, Garavaglia B, Bado M et al (] 998) Very-long-chain acyl-coenzyme A dehydrogenase deficiency in a child with recurrent myoglobinuria. Neuromusc Disord 8:3–6
Miyajima H, Orii KE, Shindo Y et al (1998) Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence. Neurology 49:833–837
Elpeleg ON, Saada AB, Shaag A et al (1997) Lipoamide dehydrogenase deficiency: A new cause for recurrent myoglobinuria. Muscle and Nerve 20:238–240
Bresolin N, Bet L, Moggio M et al (1987) Muscle G6PD deficiency. Lancet I:212–213
Bresolin N, Bet L, Moggio M et al (1989) Muscle glucose-6-phosphate dehydrogenase deficiency. J Neurol 236:193–198
Argov Z, Bank WJ (1991) Phosphorus magnetic resonance spectroscopy (31 P MRS) in neuromuscular disorders. Ann Neurol 30:90–97
Bank W, Park J, Lech G, Chance B (1998) Near-infrared spectroscopy in the diagnosis of mitochondria] disorders. BioFactors 7:243–245
Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Nat Acad Sci USA 86:2379–2382
Servidei S, Spinazzola A, Crociani P et al (1996) Replacement therapy is effective in familial mitochondrial encephalomyopathy with muscle CoQ10 deficiency. Neurology 46:A420
Sobreira C, Hirano M, Shanske Set al (1997) Mitochondria] encephalomyopathy with coenzyme QIO deficiency. Neurology 48:1238–1243
Boitier E, Degoul F, Desguerre I et al (1998) A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci 156:41–46
Rotig A, Appelkvist E-L, Geromel V et al (1997) CoQ10-responsive mitochondrial encephalomyopathy due to an inborn error of ubiquinone synthesis metabolism. Am J Hum Genet 61(Suppl):A358
Dumoulin R, Sagnol I, Ferlin T, Bozon D, Stepien G, Mousson B (1996) A novel gly290asp mitochondria) cytochrome b mutation linked to a complex III deficiency in progressive exercise intolerance. Mol Cell Probes 10:389–391
Andreu AL, Krishna S, Bruno C et al (1998) A novel G 15762A mutation in the mitochondrial cytochrome b gene. Neurology 50:A24
Kennaway NG, Buist NR, Darley Usmar VM et al (1984) Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain. Pediatr Res 18:991–999
Kennaway NG, Keightley JA, Burton MD, Quan F, Libby BD, Buist NRM (1998) Mitochondrial encephalomyopathy associated with a nonsense mutation in cytochrome b. Mol Genet Metab 63:49
Eleff S, Kennaway NG, Buist NR et al (1984) 31 P-NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Nat Acad Sci USA 81:3529–3533
Keightley JA, Hoffbuhr KC, Burton MD et al (1996) A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nature Genet 12:410–415
Saunier P, Chretien D, Wood C et al (1995) Cytochrome c oxidase deficiency presenting as recurrent neonatal myoglobinuria. Neuromusc Disord 5:285–289
Chinnery PF, Johnson MA, Taylor RW, Lightowlers RN, Turnbull DM (1997) A novel mitochondria) tRNA phenylalanine mutation presenting with acute rhabdomyolysis. Ann Neurol 41:408–410
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag France
About this chapter
Cite this chapter
DiMauro, S., Bruno, C., Andreu, A.L., Hadjigeorgiou, G.M., Shanske, S. (1999). New Aspects of Metabolic Myopathies. In: Serratrice, G., Pouget, J., Azulay, JP. (eds) Exercise Intolerance and Muscle Contracture. Springer, Paris. https://doi.org/10.1007/978-2-8178-0855-0_3
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0855-0_3
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-59669-8
Online ISBN: 978-2-8178-0855-0
eBook Packages: Springer Book Archive